全文获取类型
收费全文 | 4032篇 |
免费 | 145篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 63篇 |
妇产科学 | 11篇 |
基础医学 | 694篇 |
口腔科学 | 148篇 |
临床医学 | 523篇 |
内科学 | 339篇 |
皮肤病学 | 35篇 |
神经病学 | 9篇 |
特种医学 | 60篇 |
外科学 | 118篇 |
综合类 | 315篇 |
预防医学 | 647篇 |
眼科学 | 14篇 |
药学 | 1064篇 |
中国医学 | 119篇 |
肿瘤学 | 47篇 |
出版年
2023年 | 81篇 |
2022年 | 138篇 |
2021年 | 186篇 |
2020年 | 187篇 |
2019年 | 193篇 |
2018年 | 209篇 |
2017年 | 172篇 |
2016年 | 137篇 |
2015年 | 123篇 |
2014年 | 341篇 |
2013年 | 386篇 |
2012年 | 334篇 |
2011年 | 333篇 |
2010年 | 170篇 |
2009年 | 190篇 |
2008年 | 146篇 |
2007年 | 193篇 |
2006年 | 171篇 |
2005年 | 119篇 |
2004年 | 94篇 |
2003年 | 62篇 |
2002年 | 52篇 |
2001年 | 40篇 |
2000年 | 41篇 |
1999年 | 22篇 |
1998年 | 13篇 |
1997年 | 16篇 |
1996年 | 12篇 |
1995年 | 8篇 |
1994年 | 4篇 |
1993年 | 5篇 |
1992年 | 6篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 6篇 |
1987年 | 7篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有4216条查询结果,搜索用时 15 毫秒
11.
羊耳菊水提取物体外抑菌活性研究 总被引:3,自引:0,他引:3
目的 探讨羊耳菊不同器官水提取物的体外抑菌活性.方法 以金黄色葡萄球菌、铜绿假单胞菌、白色念珠菌等10种微生物为试验菌株,采用药敏纸片扩散法、试管二倍稀释法,对羊耳菊水提取物进行抑菌试验.结果 羊耳菊全株各器官都具有较强的抑菌作用,其中根对10种供试菌种都有抑制作用,抑制范围最广;茎对9种供试菌种有抑制作用,叶对8种供试菌种有抑制作用.羊耳菊各器官对金黄色葡萄球菌与铜绿假单胞菌的抑制作用最强.羊耳菊根、茎、叶对金黄色葡萄球菌的MIC值分别为15.63,62.5,62.5 mg/ml,而其抑菌圈直径分别为14.3,13.8,13.5 mm;羊耳菊根,茎,叶对铜绿假单胞菌的MIC值分别为15.63,31.25,62.5 mg/ml,其抑菌圈直径分别为15.8,15.5,14.0 mm.结论 羊耳菊水提取物体外试验证实了该民间药物具有抗菌活性,也表明了羊耳菊是一种有开发潜力的新抗菌药物资源. 相似文献
12.
Maite Sainz De La Maza Ramzy K. Hemady C. Stephen Foster 《Documenta ophthalmologica. Advances in ophthalmology》1993,83(1):33-41
While systemic autoimmune diseases are the main possibilities in the differential diagnosis of scleritis, other less common etiologies such as infections must also be considered. The authors report four cases of infectious scleritis to review predisposing factors, clinical characteristics, methods of diagnostic approach, and response to therapy. Two patients had primary scleritis and two patients had secondary scleritis following extension of primary corneal infection (corneoscleritis). Diagnoses included three local infections (one each withStaphylococcus. Acanthamoeba, and herpes simplex) and one systemic infection (Lyme disease). Stains, cultures, or immunologic studies from scleral, conjunctival, and/or corneal tissues, and serologic tests were used to make the diagnosis. Medical therapy, including antimicrobial agents, was instituted in all patients, and surgical procedures were additionally required in two patients (scleral grafting in one and two penetrating keratoplasties in another); the patient who required two penetrating keratoplasties had corneoscleritis and underwent eventual enucleation. Infectious agents should be considered in the differential diagnosis of scleritis. 相似文献
13.
Venera Cardile Alessandra Russo Carmen Formisano Daniela Rigano Felice Senatore Nelly Apostolides Arnold Franco Piozzi 《Journal of ethnopharmacology》2009
Aim of the study
Salvia bracteata Banks et Sol. and Salvia rubifolia Boiss. are known in folk medicine of Lebanon for the treatment of microbial infections, cancer, urinary and pulmonary problems. In the present study the chemical composition and antimicrobial activity of essential oils from aerial parts of Salvia bracteata and Salvia rubifolia collected in Lebanon were evaluated. The oils were also tested for their potential antiproliferative effects against M14 human melanoma cells.Material and methods
The oils were studied by GC and GC–MS and their antibacterial activity (MIC and MBC) was tested against ten bacteria species using the broth dilution method. The inhibitory effect on human melanoma cells (measurement of cell vitality, cell membrane integrity and genomic DNA fragmentation) was studied using MTT assay, calculation of LDH release and COMET assay.Results
The oils showed a good antibacterial activity (MIC = 50 μg/ml) against Gram+ bacteria. They besides exhibited an inhibitory effect on the human cancer cells examined inducing also apoptotic cell death, but the oil of Salvia rubifolia was significantly (p < 0.001) more active as compared to the oil of Salvia bracteata.Conclusion
The results on the pharmacological activities of these Salvia species provide an in vitro scientific support for the use of these plants in traditional herbal preparations. 相似文献14.
15.
凝固酶阴性葡萄球菌检测在慢性前列腺炎中的意义 总被引:21,自引:0,他引:21
目的 研究慢性前列腺炎与凝固酶阴性葡萄球菌 (CNS)的关系 ,探讨前列腺液中CNS检测的临床意义。 方法 对 4 2 8例慢性前列腺炎患者采用Meares Stamey四段取样法作前列腺液细菌培养和药敏试验。患者年龄 18~ 4 6岁 ,平均 31岁。病程 3~ 32个月 ,平均 6个月。慢性前列腺炎症状指数 (NIH CPSI)平均 2 3.2分。 结果 4 2 8例均行细菌培养 ,其中 2 4 8例 (5 7.94 % )分离出细菌。革兰阳性菌 195例 (78.6 3% ) ,其中葡萄球菌 16 0例 (6 4 .5 2 % ,16 0 / 2 4 8) ,CNS 89例 (35 .89% ,89/ 2 4 8) ;CNS中以表皮葡萄球菌为主者 81例 (32 .6 6 % ) ,其次为腐生葡萄球菌 3例和溶血性葡萄球菌 2例 ;NIH CPSI积分与细菌培养结果无明显相关。CNS对常用抗菌药物 (β 内酰胺类、喹诺酮类、氨基糖苷类 )耐药率较高 (5 1.9%~ 10 0 % )。 结论 CNS为慢性前列腺炎的主要致病菌 ,应引起高度重视 ;适时监测前列腺液病原菌及药敏试验对临床诊断和治疗慢性前列腺炎具有重要意义。 相似文献
16.
三联疗法根除幽门螺杆菌治疗对肠道微生态的影响 总被引:1,自引:0,他引:1
目的 探讨抗幽门螺杆菌(Hp)治疗对患者肠道菌群状态(肠道微生态)及耐药性的影响。方法 分别称取60例患者治疗前后新鲜粪便0.5g,选择肠道菌群中具代表性的4种需氧菌和6种厌氧菌分别进行需氧和厌氧培养,从培养出的菌落中挑选相同的菌株进行治疗前后药敏试验。结果 (1)治疗后肠道菌群中肠杆菌、葡萄球菌、拟杆菌、双歧杆菌、消化球菌、梭菌、乳杆菌、真杆菌均较治疗前明显降低(P<0.05);(2)治疗后肠道菌群中大肠埃希氏菌、消化链球菌、赛氏葡萄球菌、普氏梭杆菌、肺炎致病性链球菌群、产气真杆菌等对庆大霉素、红霉素、环丙沙星、特美丁、头孢噻肟钠等药耐药率明显增加,且存在多重耐药(P<0.05);(3)治疗后超广谱β—内酰氨酶阳性的消化链球菌、表皮葡萄球菌、普氏梭杆菌、肺炎致病性链球菌群、赛氏葡萄球菌等较治疗前分别增加26.2%、33.3%、28.6%、35.3%、28.6%。结论 三联抗Hp治疗后肠道菌群失调、耐药菌株的增加、传播与扩散对广大人群存在潜在危险。 相似文献
17.
Granulysin: A Novel Host Defense Molecule 总被引:5,自引:0,他引:5
Granulysin is a novel cationic molecule present in the granules of cytotoxic T lymphocytes and natural killer cells. Cytotoxic T lymphocytes have long been associated with graft destruction in transplant rejection. Recent studies implicate granulysin in cell-mediated cytotoxicity, chemoattraction, immune activation and as a potential diagnostic biomarker for transplant rejection. 相似文献
18.
V. Houdouin S. Bonacorsi P. Bidet E. Bingen 《Clinical microbiology and infection》2007,13(12):1207-1210
The susceptibility of 136 Escherichia coli isolates from cases of neonatal meningitis to amoxycillin, ceftriaxone, nalidixic acid, ciprofloxacin and gentamicin was determined in relation to the carriage of virulence factors and phylogenetic group. Only amoxycillin and nalidixic acid resistance was observed (40% and 3%, respectively). Nalidixic acid resistance alone was associated with non-virulent phylogenetic group A (50% vs. 6% of susceptible isolates; p 0.03). No difference in virulence was observed between two representative nalidixic acid-susceptible virulent group B2 isolates and their nalidixic acid-resistant derivatives in a rat model of neonatal meningitis, suggesting that nalidixic acid resistance does not affect the virulence of E. coli strains causing meningitis. 相似文献
19.
D. Felmingham C. Feldman W. Hryniewicz K. Klugman S. Kohno D. E. Low C. Mendes A. C. Rodloff 《Clinical microbiology and infection》2002,8(S2):12-42
Bacterial resistance to antibiotics in community-acquired respiratory tract infections is a serious problem and is increasing in prevalence world-wide at an alarming rate. Streptococcus pneumoniae , one of the main organisms implicated in respiratory tract infections, has developed multiple resistance mechanisms to combat the effects of most commonly used classes of antibiotics, particularly the β -lactams (penicillin, aminopenicillins and cephalosporins) and macrolides. Furthermore, multidrug-resistant strains of S. pneumoniae have spread to all regions of the world, often via resistant genetic clones. A similar spread of resistance has been reported for other major respiratory tract pathogens, including Haemophilus influenzae , Moraxella catarrhalis and Streptococcus pyogenes . To develop and support resistance control strategies it is imperative to obtain accurate data on the prevalence, geographic distribution and antibiotic susceptibility of respiratory tract pathogens and how this relates to antibiotic prescribing patterns. In recent years, significant progress has been made in developing longitudinal national and international surveillance programs to monitor antibiotic resistance, such that the prevalence of resistance and underlying trends over time are now well documented for most parts of Europe, and many parts of Asia and the Americas. However, resistance surveillance data from parts of the developing world (regions of Central America, Africa, Asia and Central/Eastern Europe) remain poor. The quantity and quality of surveillance data is very heterogeneous; thus there is a clear need to standardize or validate the data collection, analysis and interpretative criteria used across studies. If disseminated effectively these data can be used to guide empiric antibiotic therapy, and to support—and monitor the impact of—interventions on antibiotic resistance. 相似文献
20.
Alon Peled Ofer Sarig Guangping Sun Liat Samuelov Chi A. Ma Yuan Zhang Tom Dimaggio Celeste G. Nelson Kelly D. Stone Alexandra F. Freeman Liron Malki Lucia Seminario Vidal Latha M. Chamarthy Valeria Briskin Janan Mohamad Mor Pavlovsky Jolan E. Walter Joshua D. Milner Eli Sprecher 《The Journal of allergy and clinical immunology》2019,143(1):173-181.e10